Axiora Medical
Axiora Medical
Explore our flagship OEM clinical implants and surgical instruments verified under strict Class III ISO / CE certifications
Analyzing key biomechanical trajectories, clinical requirements, and material dynamics driving B2B sourcing decisions
In modern spinal arthrodesis, Anterior Cervical Discectomy and Fusion (ACDF) remains the gold standard for treating cervical disc degeneration, radiculopathy, and instability. The structural integrity and material biocompatibility of cervical interbody cages are critical factors determining fusion success and long-term mechanical stability. Historically, autografts represented the primary approach; however, donor site morbidity led to the development of synthetic interbody devices.
Today, global procurement organizations, orthopedic OEMs, and clinical teams demand advanced cervical interbody implants engineered to optimize osteointegration, mitigate subsidence risk, and maintain lordotic alignment. Achieving this requires precise raw material selection, advanced surface treatments, and highly customized biomechanical designs.
Key comparative insights into medical-grade materials and custom configurations
Polyetheretherketone (PEEK) features a Young's modulus closely aligned with human cortical bone (approx. 3-4 GPa vs. 18 GPa for bone), reducing stress shielding. Its radiolucent property allows clear imaging of the fusion mass. Custom options include tantalum markers to ensure accurate intraoperative placement.
Utilizing high-precision additive manufacturing with Titanium Alloy (Ti6Al4V ELI), our designs achieve an interconnected porous matrix with 60–80% porosity. This structure mimics trabecular bone, encouraging rapid osteogenesis and direct mechanical interlocking with the vertebral endplates.
We manufacture advanced standalone cervical interbody cages equipped with integrated screws or locking blade mechanisms. This eliminates the need for an anterior cervical plate, reducing surgical time, patient exposure, and post-operative dysphagia risks.
Axiora Medical supports customized biomechanical parameters to meet diverse anatomical requirements:
A B2B guide for supply chain optimization, risk management, and scalable medical manufacturing
For global medical device distributors, brand owners, and purchasing departments, securing a reliable contract manufacturer for Class III orthopedic spinal devices involves managing strict regulatory, supply chain, and quality control requirements. Axiora Medical simplifies this process through our comprehensive B2B infrastructure:
A major risk in medical device supply chains is regulatory rejection due to inconsistent dimensional tolerances or biocompatibility failures. To mitigate this risk, Axiora implements strict quality assurance workflows, including raw material traceability (e.g., verifying ASTM F136 Titanium and ASTM F2026 PEEK from certified sources) and validated cleanroom packaging.
Review our step-by-step workflow, utilizing advanced CNC equipment and cleanroom validation systems
Axiora Medical Technology (China) Co., Ltd. – Profile and Capabilities
Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery.
Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.
| Item Specification | Operational Details |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Website Reference | www.axioraortho.com |
| Established Year | 2017 |
| Factory Area | 18,600 m² |
| Annual Export Revenue | USD 26 Million |
| Export Experience | 8 Years |
| Industry Experience | 15 Years |
| Quality Inspection | 100% Finished Product Inspection & Incoming Material Inspection |
| Product Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Quality Control Staff | 48 Quality Specialists |
| Business Type | Manufacturer & Exporter (OEM/ODM contract manufacturer) |
| Main Markets | Europe, North America, Middle East, Southeast Asia, South America |
| Supply Chain Partners | 1,120 active partners globally |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Development, Reverse Engineering, OEM & ODM Solutions |
| Customization Options | Logo Printing, Private Label, Custom Packaging, Product Design, Material Selection, Drawing-Based Manufacturing |
| New Products Released Last Year | 126 new implant designs and variations |
| R&D Engineers | 86 structural and material engineers |
Pioneering the next generation of cervical interbody fusion platforms
We are incorporating bio-active surface modifications, such as hydroxyapatite (HA) coatings and nano-textured surface treatments on PEEK, to actively stimulate localized cellular differentiation and bone growth.
Developing customizable parameter scripts linked with healthcare providers' CT scan data. This allows surgeons to order patient-specific anatomical cages directly from the factory, improving surgical outcomes.
Designing dynamic, micro-expandable interbody cages that adapt to the patient's individual lordotic and spinal mechanics post-implantation, minimizing the risk of cage subsidence and migration.
Addressing crucial regulatory pathways and logistics questions for B2B distributors and brand owners
Ensure smooth procedures with our high-grade fixation systems and specialized instrument sets
